These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
823 related items for PubMed ID: 6952920
1. Proposals for the classification of the myelodysplastic syndromes. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Br J Haematol; 1982 Jun; 51(2):189-99. PubMed ID: 6952920 [Abstract] [Full Text] [Related]
2. Myelodysplastic syndromes: a study of 101 cases according to the FAB classification. Vallespi T, Torrabadella M, Julia A, Irriguible D, Jaen A, Acebedo G, Triginer J. Br J Haematol; 1985 Sep; 61(1):83-92. PubMed ID: 3863667 [Abstract] [Full Text] [Related]
3. Refractory anaemia with excess of blasts in transformation re-evaluated with the WHO criteria: identification of subgroups with different survival. Breccia M, Latagliata R, Carmosino I, Gentilini F, D'Elia GM, Levi A, Natalino F, Frustaci A, De Cuia MR, Alimena G. Acta Haematol; 2007 Sep; 117(4):221-5. PubMed ID: 17259693 [Abstract] [Full Text] [Related]
4. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes. Berer A, Jäger E, Sagaster V, Streubel B, Wimazal F, Sperr WR, Welterman A, Schwarzinger I, Frommlet F, Haas OA, Valent P, Lechner K, Geissler K, Ohler L. Ann Hematol; 2003 May; 82(5):271-7. PubMed ID: 12739063 [Abstract] [Full Text] [Related]
5. Physician Education: Myelodysplastic Syndrome. Yoshida Y. Oncologist; 1996 May; 1(4):284-287. PubMed ID: 10388004 [Abstract] [Full Text] [Related]
6. Myelodysplastic syndromes in patients under 50 years old: a single institution experience. Breccia M, Mengarelli A, Mancini M, Biondo F, Gentilini F, Latagliata R, Mandelli F, Alimena G. Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670 [Abstract] [Full Text] [Related]
10. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K. Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935 [Abstract] [Full Text] [Related]
13. [Clinical significance of WHO classification and MDS 2000 classification in myelodysplastic syndromes]. Akiba M, Matsuda A, Misumi M, Yagasaki F, Bessho M. Rinsho Ketsueki; 2001 Dec; 42(12):1162-9. PubMed ID: 11828718 [Abstract] [Full Text] [Related]
15. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, Bertini M, Girotto M, Marinone C, Ferrero D, Gallamini A, Levis A, Saglio G, Piedmont Study Group on Myleodysplastic Syndromes. J Clin Oncol; 2003 May 15; 21(10):1988-95. PubMed ID: 12743153 [Abstract] [Full Text] [Related]
17. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Betticher DC, Huxol H, Müller R, Speck B, Nissen C. Exp Hematol; 1993 Nov 15; 21(12):1517-21. PubMed ID: 8405233 [Abstract] [Full Text] [Related]
18. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R. Haematologica; 2006 Dec 15; 91(12):1596-604. PubMed ID: 17145595 [Abstract] [Full Text] [Related]